Yes, Gravol (dimenhydrinate) is a significant concern for patients with glaucoma and should be avoided in those with untreated angle-closure glaucoma.
Gravol contains dimenhydrinate, an antihistamine with anticholinergic properties that can cause mydriasis (pupil dilation) and precipitate acute angle-closure glaucoma, particularly in patients with narrow anterior chamber angles 1.
Why Gravol is Problematic in Glaucoma
Dimenhydrinate belongs to the class of antihistamines (specifically H1 receptor antagonists) that possess anticholinergic effects. The FDA drug label explicitly warns to "ask a doctor before use if you or your child has glaucoma" 1. This warning exists because:
- Anticholinergic medications can cause pupillary dilation (mydriasis), which increases the risk of pupillary block in susceptible individuals 2
- Histamine H1 receptor antagonists have been specifically reported to induce or precipitate acute angle-closure glaucoma, especially in individuals predisposed with narrow anterior chamber angles 3
- The mechanism involves blocking parasympathetic tone, leading to pupil dilation that can obstruct aqueous humor outflow in anatomically predisposed eyes
Type of Glaucoma Matters
The risk profile differs significantly based on glaucoma type:
Angle-Closure Glaucoma (Higher Risk)
- Gravol should be avoided in patients with untreated angle-closure glaucoma or narrow angles
- The anticholinergic effects can trigger acute angle-closure attacks, which constitute an ocular emergency
- Even dim lighting conditions (like airplane cabins) can cause mydriasis and increase pupillary block risk in predisposed individuals 2
Open-Angle Glaucoma (Lower Risk)
- The risk is substantially lower in open-angle glaucoma patients
- However, caution is still warranted as anticholinergic medications can theoretically affect intraocular pressure regulation
Clinical Decision Algorithm
Before prescribing Gravol to any patient:
- Ask specifically about glaucoma history - type of glaucoma matters critically
- If angle-closure glaucoma or narrow angles: Do not use; recommend alternative antiemetics without anticholinergic properties
- If open-angle glaucoma with good control: May use with caution and ophthalmologist consultation
- If glaucoma type unknown: Refer to ophthalmologist before use, or choose safer alternative
Safer Alternatives for Nausea/Motion Sickness
For patients with glaucoma requiring antiemetic therapy, consider:
- Ondansetron (5-HT3 antagonist) - no anticholinergic effects
- Metoclopramide - though use caution with other contraindications
- Ginger supplements for mild motion sickness
- Scopolamine patches (though also anticholinergic, may be used under ophthalmologic supervision in specific cases)
Common Pitfall to Avoid
The product label states "ask a doctor before use if you have glaucoma" but does not specify which type of glaucoma 1. This vague warning leads to confusion. Clinicians must recognize that the primary concern is angle-closure glaucoma or anatomically narrow angles, not all glaucoma types equally. However, when in doubt, consultation with an ophthalmologist is mandatory before prescribing anticholinergic medications to any glaucoma patient.
The broader context from obesity treatment guidelines reinforces this principle: when managing patients with glaucoma, medications with anticholinergic properties should either be avoided entirely or used only with extreme caution and specialist input 4.